The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

Neurogene (NASDAQ: NGNE) stock just took a sharp dive, plummeting 44% in a single day. Bad news on Monday caused the ...

Furthermore, improvement in end markets given increasing clarity from the Chinese government stimulus package and improving ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search ... While Pfizer already counts on ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Legend Biotech Corporation ( (LEGN) ) has released its Q3 earnings. Here is a breakdown of the information Legend Biotech Corporation presented ...

Now, the biotech has struck a deal to gain full control of PM8002 ... That still left room for rivals to generate blockbuster ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Legend Biotech (LEGN) has released an update. Legend Biotech’s revenues soared in the third quarter of 2024, driven by the impressive ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Shares of the U.S. biotech firm fell 3% to $8.73. The U.S. vaccine maker now expects between $175 million and $225 million ...